DNA X, Inc. SONM
3.92
(0.03)
(0.76%)
as of 25 Sep
- Market cap
- $5.9M
- P/E
- 0.0×
Follow SONM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(455.82%) | 302.56% | 1,433.07% | 666.17% | |
| (74.71%) | (49.40%) | (72.43%) | (42.11%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
396.72% | 95.12% | 1,451.38% | 383.79% | |
Average Days of Receivables |
82.37 | — | 0.00 | 0.00 | |
Free Cash Flow per Share |
(26.43) | (32.55) | (11.23) | (8.36) | |
Free Cash Flow |
(26.03) | (23.53) | (14.21) | (11.29) | |
Capital Expenditures |
— | — | 3.17 | 3.21 | |
Piotroski F-Score |
3.00 | 1.00 | — | — | |
| Other line items | |||||
Cash ROIC |
(1,543.95%) | 353.67% | (8,200.94%) | 4,368.98% | |
Accounts Receivable Turnover |
5.02 | — | 0.00 | 0.00 | |
Accounts Payable Turnover |
(0.01) | 7.85 | 0.00 | 0.00 | |
Inventory Turnover |
(0.01) | 0.00 | — | — | |
Average Days of Payables |
(72,319.61) | 78.62 | 0.00 | 0.00 | |
Days of Inventory on Hand |
(38,930.97) | 0.00 | — | — | |
Tax Rate |
(0.22) | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
25.77% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
(9.54%) | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
2.94% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 1.14 | 1.18 | 1.70 | |
Depreciation/Fixed assets |
26.56 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.98 | 1.24 | |
Revenue per Share |
60.02 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(26.43) | (32.55) | (13.74) | (10.74) | |
Capex per Share |
0.00 | 0.00 | 2.51 | 2.38 | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
(56.48%) | 0.00% | 0.00% | 0.00% |
Columns are period end dates